GlobeImmune Announces Updates and Financial Results for First Quarter 2016
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall St kicks off September under pressure as higher yields, oil prices weigh
- Oil prices rise 2% as US-Iran fighting stokes supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
- The Warsh pivot markets didn't expect
UPDATE: GlobeImmune (GBIM) Reports Q1 Loss Per Share of 15c, Continues to Evaluate Strategic Alternatives
May 12, 2016 9:31 AM EDT(Updated - May 12, 2016 9:33 AM EDT)
(Update correct comparable figure to year-over-year results, not analyst estimates)
GlobeImmune (NASDAQ: GBIM) reported Q1 EPS of ($0.15), $0.12 better than last year ($0.27).
At March 31, 2016, GlobeImmune had cash and equivalents of $8.7 million. The Company... More
